Desarrollo de un Sistema de Control y Digitalización de Pruebas Psicotécnicas para GNEX Gabinete Psicotécnico

138 p.En nuestro país, como en cualquier parte del mundo el conducir un vehículo moto-rizado conlleva una enorme responsabilidad, por ello se hace indispensable demostrar que se está capacitado para dicho ejercicio. Para obtener un permiso de conducción se debe acreditar un adecuado estado moral, psíquico y físico, además de contar con los conocimientos teóricos y prácticos de conducción enmarcados dentro de las dis- posiciones legales y reglamentarias dispuestas por la legislación vigente. Dentro del contexto psíquico y físico los municipios realizan evaluaciones psicosen-sométricas con un equipo de evaluación que mide la concentración, la velocidad de reacción y el nivel de visión entre otras habilidades, este equipo se conoce como gabinete psicotécnico [1]. Este proyecto tiene como objetivo el desarrollo de un sistema de software para el control de un gabinete psicotécnico denominado Gnex, desarrollado por la empresa Exceed Ltda. Este software tiene como finalidad el control centralizado de las distintas pruebas que conforman el gabinete y la administración de datos emanados de cada evaluación, permitiendo entre otras cosas: Evitar el falseo de resultado por parte de los evaluadores en perjuicio o beneficio de quien está siendo evaluado. La idea es que los resultados de las interacciones del evaluado con las pruebas sean leídas y registradas por el software y no dependan del juicio de quien está realizando la evaluación, mejorando de esta forma la veracidad de los resultados. Dar mayor confianza del resultado de los exámenes psíquicos a los evaluados; reemplazando las pruebas mecánicas por pruebas virtuales, las cuales permiten visualizar de forma gráfica e inequívoca los errores y/o aciertos cometidos. Tener un registro histórico de los resultados de las evaluaciones realizadas. Permitir el control de pruebas y la obtención de resultados desde otras aplicaciones, (comúnmente usadas para la gestión de licencias de conducir) mediante el uso de una interfaz de interoperabilidad./ABSTRACT: In our country as elsewhere in the world to drive a motor vehicle carries enormous responsibility, so it is essential to demonstrate to be qualified for that practice.To obtain a driving license you must demonstrate an adequate moral, mental and physical status, in addition you need to have a theoretical and practical knowledge of driving according to the laws and regulations set by the legislation. In the context of physical and psychological the municipalities made psychometric evaluations, with an equipement that measures the concentration, the reaction rate and the level of vision, among other skills, this equipement is known as psycho cabinet [1]. This project aims to develop a software system for controlling a psycho cabinet called GNEX, developed by Exceed Company Ltd. This software objetive is the centralized control of various tests that are part of cabinet and management data obtained from each test, allowing among other things: Avoid falsified results by evaluator in aid or benefit of who are being evaluated. The idea is that the interactions results of evaluated with tests are read and recorded by the software does not depend on the judgment of who is making the evaluation, thereby improving the accuracy of the results. Give greater confidence psychic test results for evaluated, replacing mechani- cal testing for virtual testing, allowing graphical display of mistakes and / or successes done. To have a historical record of evaluations results. Allow the control and obtaining of testing results from another applications (commonly used for managing drivers licenses) through an interoperability interface .

Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

Objectives: This study aimed to assess the real use of cefazolin for methicillin-susceptible Staphylococcus aureus (MSSA) infective endocarditis (IE) in the Spanish National Endocarditis Database (GAMES) and to compare it with antistaphylococcal penicillin (ASP). Methods: Prospective cohort study with retrospective analysis of a cohort of MSSA IE treated with cloxacillin and/or cefazolin. Outcomes assessed were relapse; intra-hospital, overall, and endocarditis-related mortality; and adverse events. Risk of renal toxicity with each treatment was evaluated separately. Results: We included 631 IE episodes caused by MSSA treated with cloxacillin and/or cefazolin. Antibiotic treatment was cloxacillin, cefazolin, or both in 537 (85%), 57 (9%), and 37 (6%) episodes, respectively. Patients treated with cefazolin had significantly higher rates of comorbidities (median Charlson Index 7, P <0.01) and previous renal failure (57.9%, P <0.01). Patients treated with cloxacillin presented higher rates of septic shock (25%, P = 0.033) and new-onset or worsening renal failure (47.3%, P = 0.024) with significantly higher rates of in-hospital mortality (38.5%, P = 0.017). One-year IE-related mortality and rate of relapses were similar between treatment groups. None of the treatments were identified as risk or protective factors. Conclusion: Our results suggest that cefazolin is a valuable option for the treatment of MSSA IE, without differences in 1-year mortality or relapses compared with cloxacillin, and might be considered equally effective